Orphazyme (Denmark) Probability of Future Stock Price Finishing Under 83.2
| ORPHA Stock | DKK 1,075 19.60 1.79% |
Orphazyme |
Orphazyme Target Price Odds to finish below 83.2
The tendency of Orphazyme Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to kr 83.20 or more in 90 days |
| 1,075 | 90 days | 83.20 | near 1 |
Based on a normal probability distribution, the odds of Orphazyme to drop to kr 83.20 or more in 90 days from now is near 1 (This Orphazyme AS probability density function shows the probability of Orphazyme Stock to fall within a particular range of prices over 90 days) . Probability of Orphazyme AS price to stay between kr 83.20 and its current price of kr1074.8 at the end of the 90-day period is about 16.13 .
Assuming the 90 days trading horizon Orphazyme has a beta of 0.17. This indicates as returns on the market go up, Orphazyme average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Orphazyme AS will be expected to be much smaller as well. Additionally Orphazyme AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Orphazyme Price Density |
| Price |
Predictive Modules for Orphazyme
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Orphazyme AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Orphazyme's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Orphazyme Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Orphazyme is not an exception. The market had few large corrections towards the Orphazyme's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Orphazyme AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Orphazyme within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.23 | |
β | Beta against NYSE Composite | 0.17 | |
σ | Overall volatility | 98.57 | |
Ir | Information ratio | -0.06 |
Orphazyme Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orphazyme for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orphazyme AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orphazyme AS generated a negative expected return over the last 90 days | |
| Orphazyme AS has high historical volatility and very poor performance | |
| The company reported the revenue of 36.19 M. Net Loss for the year was (626.54 M) with profit before overhead, payroll, taxes, and interest of 36.19 M. | |
| Orphazyme AS has accumulated about 726.93 M in cash with (602.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.8. |
Orphazyme Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orphazyme Stock often depends not only on the future outlook of the current and potential Orphazyme's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orphazyme's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 35 M |
Orphazyme Technical Analysis
Orphazyme's future price can be derived by breaking down and analyzing its technical indicators over time. Orphazyme Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orphazyme AS. In general, you should focus on analyzing Orphazyme Stock price patterns and their correlations with different microeconomic environments and drivers.
Orphazyme Predictive Forecast Models
Orphazyme's time-series forecasting models is one of many Orphazyme's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orphazyme's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Orphazyme AS
Checking the ongoing alerts about Orphazyme for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orphazyme AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orphazyme AS generated a negative expected return over the last 90 days | |
| Orphazyme AS has high historical volatility and very poor performance | |
| The company reported the revenue of 36.19 M. Net Loss for the year was (626.54 M) with profit before overhead, payroll, taxes, and interest of 36.19 M. | |
| Orphazyme AS has accumulated about 726.93 M in cash with (602.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.8. |
Check out Orphazyme Backtesting, Orphazyme Valuation, Orphazyme Correlation, Orphazyme Hype Analysis, Orphazyme Volatility, Orphazyme History as well as Orphazyme Performance. Note that the Orphazyme AS information on this page should be used as a complementary analysis to other Orphazyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Orphazyme Stock analysis
When running Orphazyme's price analysis, check to measure Orphazyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme is operating at the current time. Most of Orphazyme's value examination focuses on studying past and present price action to predict the probability of Orphazyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme's price. Additionally, you may evaluate how the addition of Orphazyme to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |